Roles of NF-κB in Cancer and Their Therapeutic Approaches

Although mortality rates have declined in recent years, the majority of cancers are still difficult to treat and the medical need for better cancer treatment is evident. The current anticancer armamentarium includes many active agents that are applied across tumor types. However, most of these broad...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awdur: Véronique Baud (Ed.)
Fformat: Online
Iaith:Saesneg
Cyhoeddwyd: MDPI - Multidisciplinary Digital Publishing Institute 2021
Pynciau:
Mynediad Ar-lein:27464
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
_version_ 1869528635385315328
author Véronique Baud (Ed.)
author_browse Véronique Baud (Ed.)
author_facet Véronique Baud (Ed.)
author_sort Véronique Baud (Ed.)
collection Directory of Open Access Books
description Although mortality rates have declined in recent years, the majority of cancers are still difficult to treat and the medical need for better cancer treatment is evident. The current anticancer armamentarium includes many active agents that are applied across tumor types. However, most of these broadly-active anticancer drugs have a small therapeutic index and barely discriminate between malignant and normal cells. In recent years the focus has shifted to the development of rationally designed, molecularly-targeted therapy for the treatment of a specific cancer, therefore offering the promise of greater specificity coupled with reduced systemic toxicity. NF-kB transcription factor family as emerged as such a promising target for cancer therapy. This Special Issue will explore the routes from NF-kB basic research, cancer research and oncogenomics into the development of NF-kB-based cancer therapeutics and biomarkers. We invite research and review papers in any area of the NF-kB field that are related, but not limited to, fundamental understanding of NF-kB signaling pathways, gene expression profiling, epigenetic regulation, diagnostic, prognostic and pharmacogenomic biomarkers, molecular targets driving the progression of human cancers, cancer drug development on these targets, clinical trial with new agents, and validation in animal models. We hope that this Special Issue reflects the exciting era that we are living in with respect to the field of NF-kB and its applications in cancer research.
format Online
id doab-20.500.12854ir-58619
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-586192024-04-05T12:33:28Z Roles of NF-κB in Cancer and Their Therapeutic Approaches Véronique Baud (Ed.) QH301-705.5 RC254-282 solid tumors hematological malignancies animal models biomarkers cancer targeted therapeutics oncogenomics mechanism-based drug development cancer targeted diagnosis molecular targets NF-kB subunit epigenetics NF-kB signaling pathways miRNA ubiquitin-proteasome pathway clinical trials gene expression profiling thema EDItEUR::P Mathematics and Science::PS Biology, life sciences Although mortality rates have declined in recent years, the majority of cancers are still difficult to treat and the medical need for better cancer treatment is evident. The current anticancer armamentarium includes many active agents that are applied across tumor types. However, most of these broadly-active anticancer drugs have a small therapeutic index and barely discriminate between malignant and normal cells. In recent years the focus has shifted to the development of rationally designed, molecularly-targeted therapy for the treatment of a specific cancer, therefore offering the promise of greater specificity coupled with reduced systemic toxicity. NF-kB transcription factor family as emerged as such a promising target for cancer therapy. This Special Issue will explore the routes from NF-kB basic research, cancer research and oncogenomics into the development of NF-kB-based cancer therapeutics and biomarkers. We invite research and review papers in any area of the NF-kB field that are related, but not limited to, fundamental understanding of NF-kB signaling pathways, gene expression profiling, epigenetic regulation, diagnostic, prognostic and pharmacogenomic biomarkers, molecular targets driving the progression of human cancers, cancer drug development on these targets, clinical trial with new agents, and validation in animal models. We hope that this Special Issue reflects the exciting era that we are living in with respect to the field of NF-kB and its applications in cancer research. 2021-02-12T02:30:02Z 2021-02-12T02:30:02Z 2018-08-15 10:52:09 2018 book 27464 9783038971177 9783038971184 https://directory.doabooks.org/handle/20.500.12854/58619 eng image/jpeg Attribution-NonCommercial-NoDerivatives 4.0 International http://www.mdpi.com/books/pdfview/book/711 http://www.mdpi.com/books/pdfview/book/711 MDPI - Multidisciplinary Digital Publishing Institute 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783038971177 9783038971184 X, 330 open access
spellingShingle QH301-705.5
RC254-282
solid tumors hematological malignancies
animal models
biomarkers
cancer targeted therapeutics
oncogenomics
mechanism-based drug development
cancer targeted diagnosis
molecular targets
NF-kB subunit
epigenetics
NF-kB signaling pathways
miRNA
ubiquitin-proteasome pathway
clinical trials
gene expression profiling
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
Véronique Baud (Ed.)
Roles of NF-κB in Cancer and Their Therapeutic Approaches
title Roles of NF-κB in Cancer and Their Therapeutic Approaches
title_full Roles of NF-κB in Cancer and Their Therapeutic Approaches
title_fullStr Roles of NF-κB in Cancer and Their Therapeutic Approaches
title_full_unstemmed Roles of NF-κB in Cancer and Their Therapeutic Approaches
title_short Roles of NF-κB in Cancer and Their Therapeutic Approaches
title_sort roles of nf κb in cancer and their therapeutic approaches
topic QH301-705.5
RC254-282
solid tumors hematological malignancies
animal models
biomarkers
cancer targeted therapeutics
oncogenomics
mechanism-based drug development
cancer targeted diagnosis
molecular targets
NF-kB subunit
epigenetics
NF-kB signaling pathways
miRNA
ubiquitin-proteasome pathway
clinical trials
gene expression profiling
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
topic_facet QH301-705.5
RC254-282
solid tumors hematological malignancies
animal models
biomarkers
cancer targeted therapeutics
oncogenomics
mechanism-based drug development
cancer targeted diagnosis
molecular targets
NF-kB subunit
epigenetics
NF-kB signaling pathways
miRNA
ubiquitin-proteasome pathway
clinical trials
gene expression profiling
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
url 27464
work_keys_str_mv AT veroniquebauded rolesofnfkbincancerandtheirtherapeuticapproaches